The evolution of "Biotechnology"

Kate Wilhelm's *Where Late the Sweet Birds Sang* (1976) introduces biotech as desperate triage — cloning as ark, biology conscripted to preserve the species after ecological collapse. The technology works, but the copies lose something irreplaceable: individuality atrophies in the name of survival. Cherryh's *Cyteen* (1988) takes that loss and makes it a political instrument — the clones aren't emergency measures but manufactured citizens, their psychologies engineered for state purposes, and the novel's central horror is that the engineering *succeeds*. By the time Di Filippo's *Ribofunk* (1996) arrives, biotech has become ambient infrastructure, played for punk exuberance rather than dread, as if the culture had briefly metabolized its anxiety. Then Bacigalupi's *The Windup Girl* (2009) completes the inversion: biotech is no longer a tool humans wield but the substrate of a new political economy — calorie companies replace oil companies, engineered plagues enforce market dominance, and a manufactured person is simultaneously commodity and conscience. What's striking across the arc is the steady migration of agency: biotech moves from something we do *to* nature, to something done *to* us, to something that simply *is* the operating system. Suleyman and Bhaskar's *The Coming Wave* (2023) arrives as nonfiction confirmation of the trajectory the novelists already mapped, but without their crucial insight — that the deepest problem was never capability but the question of who counts as a person when personhood itself becomes a design parameter.